Kovack Advisors’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Kovack Advisors's EXAS Position: Q1 2026 in Review
Kovack Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,359 shares — an estimated $240K sold.
Kovack Advisors first reported a position in EXAS in Q2 2017 and held it in 18 quarters. The position peaked at $569K in Q4 2017. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Kovack Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Kovack Advisors sold 2,359 Exact Sciences shares in Q1 2026, an estimated $240K.
- Kovack Advisors first reported a position in Exact Sciences in Q2 2017 and held it in 18 quarters.
- Kovack Advisors's Exact Sciences position peaked at $569K in Q4 2017.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Kovack Advisors's 13F filing for Q1 2026, filed 13 May 2026.